Almac Group is investing £16 million to expand its formulation and analytical development services at Charnwood Campus in Loughborough, a science, technology and enterprise park, with an operational start date targeted for 1Q17. Almac will occupy the formulation development and analytical testing facilities at the site, which will complement development & GMP services offered from its Craigavon NI Headquarters. 
 
The Charnwood facilities were originally designed and built by a global Pharma company as part of its in-house formulation development, clinical manufacturing and analytical testing capabilities. Almac is recommissioning the facilities with operations focusing initially on expanding both non-potent and potent solid oral dose processing, creating approximately 180 new jobs in the next five years.  
 
Graeme McBurney, managing director, Almac Pharma Services said, “As we experience increased client demand for our pharmaceutical development and niche commercial manufacturing services, this latest expansion will significantly enhance Almac’s offering, increasing capacity and capability and further demonstrating our continued commitment to support our global clients in the development and manufacturing of their drug products.”